Testing Protocol. Contractor shall execute a contract with all SoonerCare providers, or their authorized designee, for submitting and receiving MMIS data. Said contract must stipulate that SoonerCare providers, or their authorized designee, must utilize software tested and approved by Contractor as being in the proper format and compatible with the MMIS system. Contractor agrees to submit test transactions to ES prior to the submission of initial transactions of each individual transaction type to the MMIS production system, to determine that the transactions and responses comply with all requirements and specifications approved by the State of Oklahoma. The parties agree that ES and OHCA will make the sole determination that test data is acceptable. This capability to submit test transactions will be maintained by Contractor throughout the term of this Agreement. Furthermore, Contractor agrees to submit only those individual transaction types that ES has previously approved. Contractor agrees that prior to the submission of any additional transaction types to the MMIS production system, or as a result of making changes to an existing transaction type or system, to submit test transactions to ES. Additionally, Contractor shall release MMIS transmitted data only to authorized parties who have signed contracts with the Contractor. Successful testing means the ability to pass all HIPAA compliance standards, and to process electronic healthcare information transmitted by Contractor to ES.
Testing Protocol. Contractor shall execute a contract with all SoonerCare providers, or their authorized designee, for submitting and receiving MMIS data. Said contract must stipulate that SoonerCare providers, or their authorized designee, must utilize software tested and approved by Contractor as being in the proper format and compatible with the MMIS system. Contractor agrees to submit test transactions to Gainwell prior to the submission of initial transactions of each individual transaction type to the MMIS production system, to determine that the transactions and responses comply with all requirements and specifications approved by the State of Oklahoma. The parties agree that Xxxxxxxx and OHCA will make the sole determination that test data is acceptable. This capability to submit test transactions will be maintained by Contractor throughout the term of this Agreement. Furthermore, Contractor agrees to submit only those individual transaction types that Xxxxxxxx has previously approved. Contractor agrees that prior to the submission of any additional transaction types to the MMIS production system, or as a result of making changes to an existing transaction type or system, to submit test transactions to Gainwell. Additionally, Contractor shall release MMIS transmitted data only to authorized parties who have signed contracts with the Contractor. Successful testing means the ability to pass all HIPAA compliance standards, and to process electronic healthcare information transmitted by Contractor to Gainwell.
Testing Protocol. Contractor’s staff shall be on call 24 hours a day, 365 days a year to assist the SFMTA and designated taxi company(ies) with post-accident testing, reasonable suspicion or other urgent testing situations. Contractor shall make all arrangements with the collection site to ensure its availability for testing. Contractor shall engage all required collection personnel. Urine Drug Collectors (UDC) personnel shall meet all certification and training requirements described in 49 CFR Part 40 Subpart C. The UDC shall use equipment authorized under, and follow all collection procedures described in, 49 CFR Part 40 Subparts C, D, E, and I. As mentioned above, the only exception is that all urine screens shall be conducted using a non-DOT chain-of-custody form. Breath Alcohol Technicians (BAT) shall meet all certification and training requirements described in 49 CFR Part 40 Subpart J. The BAT shall use equipment authorized under, and follow all procedures described in, 49 CFR Part 40 Subparts J, K, L, M, and N. All breath testing shall be conducted using a non-DOT alcohol testing form. Contractor shall provide all specimen collection supplies needed for urine collection, including:
1. Specimen collection and bottle containers.
2. Non-DOT chain-of-custody (COC) forms pre-printed with account information.
3. Pre-printed return envelopes for the collector to mail a copy of the COC form to the Medical Review Officer (MRO).
4. Specimen shipping box to protect the sample during shipping.
5. Courier overnight shipping envelope for sending specimens to the designated laboratory that has been certified by the U.S. Department of Health and Human Services (DHHS).
6. The initial supply of testing materials, to be shipped directly to the designated collection site(s). Contractor shall provide the collection site(s) with detailed instructions concerning the establishment of accounts for each designated taxi company, including:
1. The designated taxi company name, contact information, and authorized contacts.
2. The names, addresses, and contact information of the testing laboratory and the MRO.
3. Specimen shipping instructions.
4. Instructions on how to order additional testing supplies.
5. Instructions on the disbursement of testing paperwork.
Testing Protocol. The collection of samples and administration or drug and alcohol tests shall follow all standards, procedures and protocols set forth by the U.S. Department of Health and Human Services Substance Abuse and Mental Health Administration (SAMHSA). Test results will be obtained by a qualified laboratory as defined elsewhere in this policy and results shall undergo a medical review as follows:
a. All test results shall be submitted for medical review by a Medical Review Officer (MRO) of the County's choosing, who shall consider the medical history of the employee or applicant, as well as relevant biomedical information.
b. If there is a positive test result, the employee or applicant will be given an opportunity to report to the MRO the use of any prescription or over-the• counter medication.
c. If the MRO determines that there is a legitimate medical explanation for a positive test result, the MRO may certify that the test results do not indicate the unauthorized use of alcohol or a controlled substance.
d. If the MRO determines, after appropriate review, that there is not a medical explanation for the positive test result other than the unauthorized use of alcohol or a prohibited drug, the MRO shall refer the individual tested to the County Judge-executive or his/her authorized representative for further proceedings in accordance with CFC’s Drug Free Workplace Policy. Note: MRO determinations concerning the use of alcohol or a controlled or illicit substance shall comply with all procedures outlined in the U. S. Department of Health and Human Services (SAMHSA) "Medical Review Officer Manual for Federal Drug Testing Programs".
Testing Protocol. Our database, for the most part, considers various fake ears; five scenarios are designed for the test protocol. We consider the two imaging qualities explicitly (Normal quality test, High-quality test) and the three fake ear attack types (Photo attack, Video Attacks, and Display attack). The data are apportioned into 80% training and 20% test sets.
Testing Protocol. All samples shall be collected at facilities that comply with strict Department of Health and Human Services / Substance Abuse & Mental Health Services Administration (DHHS/SAMHSA) guidelines. All drug and alcohol testing will be performed at a DHHS/SAMHSA certified laboratory and shall be forwarded to a licensed Medical Review Officer (MRO). The MRO shall be chosen by the industrial health clinic and shall only report the final results to the District's CEO/Port Director. The MRO (or designee) will inform the CEO/Port Director of negative test results within 24 hours of receipt of the results. A Federally certified laboratory must verify all positive test results. The District will pay the cost of the test and reasonable transportation costs to the testing facility. The final results shall be reported to the District in writing and in a confidential manner and shall be limited only to whether the employee passed or failed the drug test. Employees who fail the drug test will be considered to have violated this policy and will be disciplined, up to and including termination, accordingly. Any employee subject to testing under this policy will be asked to sign a form acknowledging the procedures governing testing and consenting to (1) the collection of samples of urine for the purpose of determining the presence of alcohol or drugs, and (2) the release to the District of medical information regarding the test results. Refusal to sign the agreement and consent form, or to submit to the drug test, will result in either the revocation of a prospective employee’s job offer or discipline of a current employee up to and including immediate termination.
Testing Protocol a. Butterfly Valves: • Seat leakage test at rated pressure • Body test pressure at 1.5 times the rated pressure • Disc strength test at body test pressure
b. Sluice Valves: • Seat leakage test at rated pressure • Body test pressure at 1.5 times the rated pressure
c. Check (non-return) Valves: • Seat leakage test at rated pressure • Body test pressure at 1.5 times rated pressure
d. Pressure Reducing Valves • Seat leakage test at rated pressure • Body test pressure at 1.5 times rated pressure
e. Air Valves: • Function and performance tests as specified in clause 12.4 of IS 14845 • Body test pressure at 1.5 times rated pressure
f. Dismantling Joints: • Body test pressure at 1.5 times rated pressure
Testing Protocol. A. Testing for drugs will be conducted by urinalysis. A breath alcohol technician (BAT) using an approved breath-testing device will conduct testing for alcohol. In a post-accident testing mode a blood test for alcohol may be administered if a breath test is 201 0-20 14 CBA Local 28 IAFF impractical. If the employee tests positive, the MRO will provide the employee with a copy of the test results.
B. A qualified provider will conduct all drug and alcohol collections.
C. Drug Testing: Drug testing will be conducted by analyzing an employee's urine specimen. The analysis will be performed at laboratories certified and monitored by SAMHSA and DHHS. The employee will provide a urine specimen in a location that affords privacy; and the "collector" seals and label the specimen, complete a custody and control form (CCF) and prepare the specimen and accompanying paperwork for shipment to a drug testing laboratory in the presence of the employee. The specimen collection procedures and chain of custody will ensure that the specimen's security, proper identification and integrity are not compromised. Drug testing will include split specimen procedures. Each urine specimen will be subdivided into two (2) bottles labeled as a "primary" and a "split" specimen. Both bottles will be sent to a laboratory. If the analysis of the primary specimen confirms the presence of illegal or controlled substances, the employee has 72 hours to request the split specimen be sent to another SAMHSAlDHHS certified laboratory for analysis at the employee's expense. If the split specimen proves to be negative, the City will pay the expense. This split specimen procedure essentially provides the employee with an opportunity for a "second opinion."
D. The Medical Review Officer (MRO) is responsible for:
(i) The Notification Procedure
(a) Upon a positive test result, the MRO must contact the employee directly on a confidential basis and determine whether the employee wants to discuss the test result. In making the contact the MRO 2010-2014 CBA Local 28 IAFF must explain to the employee that if he/she declines to discuss the test result the MRO will verifY a positive result.
(b) The MRO must attempt to reach the employee using the day and/or evening phone numbers provided on the custody and control form (CCF), over a period of at least 24 hours using reasonable efforts.
(c) Documenting the attempts to contact the employee with dates and times.
(d) Contacting the Designated Employer Representativ...
Testing Protocol a detailed narrative description of: (a) the procedures performed; (b) the sampling units; and (c) the universe from which the sample was selected; and
Testing Protocol. In order to promote amicable employer-employee relations, The College of New Jersey (the College) and The College of New Jersey Federation of Teachers, Local 2364, AFT (the Union), on behalf of all bargaining unit members subject to the State Colleges/Universities Unit and the State Colleges/Universities Adjunct Unit collective negotiation agreements (Bargaining Unit Members), intending to be legally bound hereby, do hereby agree to the following:
